Growth Stocks
Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.
And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.
There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:
- Invest mainly in well-established companies;
- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
- Downplay or avoid stocks in the broker/media limelight.
Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.
Read More
Close
Growth Stocks Library Archives
Merck continues to make savvy acquisitions to expand its pipeline and stay ahead of rivals. Pharma inneuroscience is a promising field, and Merck’s latest purchase should accelerates its growth in this area.
MERCK & CO. INC., $106.34, is a buy. The drugmaker (New York symbol MRK; TSINetwork Rating: Above Average) (www.merck.comwww.merck.com; Shares outstanding: 2.5 billion; Market cap: $271.4 billion; Dividend yield: 3.0%) has agreed to buy Caraway Therapeutics for up to $610 million.
Launched five years ago, Caraway specializes in studying the waste disposal mechanisms of cells....
MERCK & CO. INC., $106.34, is a buy. The drugmaker (New York symbol MRK; TSINetwork Rating: Above Average) (www.merck.comwww.merck.com; Shares outstanding: 2.5 billion; Market cap: $271.4 billion; Dividend yield: 3.0%) has agreed to buy Caraway Therapeutics for up to $610 million.
Launched five years ago, Caraway specializes in studying the waste disposal mechanisms of cells....
ALIMENTATION COUCHE-TARD, $77.28, is a buy. This retailer (Toronto symbol ATD; TSINetwork Rating: Average) (couchetard.com; Shares outstanding: 963.6 million; Market cap: $74.5 billion; Dividend yield: 0.9%) continues to boost your returns through dividends and share buybacks.
The company keeps aggressively repurchasing its shares, which helps increase your share price....
The company keeps aggressively repurchasing its shares, which helps increase your share price....
ATS Corp., based in Cambridge, Ontario, is a new pick for subscribers to Power Growth Investor. The company is at the forefront of the rapidly expanding market for factory automation technology. Part of that is its big move into EV battery assembly systems, as well as industries where reliability and system integrity are key such as food and beverage, and life sciences....
TELUS INTERNATIONAL (CDA) INC. $10 remains a buy for aggressive investors. The operator of call centres (Toronto symbol TIXT; Aggressive Growth Portfolio; Manufacturing sector; Shares outstanding: 274.0 million; Market cap: $2.7 billion; Price-to-sales ratio: 0.8; No dividend paid; TSINetwork Rating: Average; www.telusinternational.com) paid $1.17 billion in January 2023 for 86% of WillowTree (all amounts except share price and market cap in U.S....
ATCO LTD. (class I non-voting) is a buy. The company (Toronto symbols ACO.X [class I non-voting] $38 and ACO.Y [class II voting] $38; Income Portfolio, Utilities sector; Shares outstanding: 113.4 million; Market cap: $4.3 billion; Price-to sales ratio: 0.9; Dividend yield: 5.0%; TSINetwork Rating: Above Average; www.atco.com) gets 80% of its revenue from its stake in Canadian Utilities Ltd....
These four food and beverage makers face several obstacles to earnings growth, including rising costs for ingredients and labour and higher interest expenses. As a result, they have raised their selling prices to offset those higher input costs. They are also adding new products in response to changing consumer tastes.
We like the long-term prospects of all four, but see only Andrew Peller as a buy for right now.
SAPUTO INC....
We like the long-term prospects of all four, but see only Andrew Peller as a buy for right now.
SAPUTO INC....
Loblaw is ready to thrive in a post-COVID-19 environment. Many of its customers who opted for home delivery (or in-store pickup) during pandemic lockdowns are sticking with that value-added service. The company’s improvements to its loyalty programs should also drive additional spending per visit, both in its stores and on its websites.
The stock lets you tap this growth and the company’s other successful retailing strategies....
The stock lets you tap this growth and the company’s other successful retailing strategies....
Motorola Solutions recently hit a new all-time high of $323, and is now up a whopping 740% since the old Motorola Inc. spun off its cellphone business as a separate firm in January 2011. The remaining operations, which make police radios and related equipment, became Motorola Solutions....
GE HEALTHCARE TECHNOLOGIES INC. $74 is a buy. The company (Nasdaq symbol GEHC; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 455.2 million; Market cap: $33.7 billion; Price-to-sales ratio: 1.7; Dividend yield: 0.2%; TSINetwork Rating: Average; www.gehealthcare.com) took its current form in January 2023 when former parent company General Electric Co....
CINTAS CORP. $555 remains a buy for aggressive investors. The stock (Nasdaq symbol CTAS; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 101.9 million; Market cap: $56.6 billion; Price-to-sales ratio: 6.4; Dividend yield: 1.0%; TSINetwork Rating: Average; www.cintas.com) has gained 22% in the past year, hitting a new all-time high of $559 in November 2023....